AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2023
Mar 31, 2023
35038_dirs_2023-03-30_f1c58476-fcd3-4660-9185-a7986ba190ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2023-03-29
Reporting Person: JOHNSON JAMES A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-29 | Common Stock | P | 5000 | $2.40 | Acquired | 5000 | Direct |
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Registration Form
2026
Apr 1
Registration Form
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Registration Form
2026
Jan 20
Registration Form
2026
Jan 20